Modulating mTOR-dependent astrocyte substate transitions to alleviate neurodegeneration

Area of Science:

• Neuroscience
• Cell Biology
• Molecular Biology

Background:

• Astrocyte heterogeneity is crucial in neuroinflammation and neurodegenerative diseases.
• Previous studies focused on static astrocyte properties, overlooking dynamic states.

Purpose of the Study:

• To investigate the dynamic states of reactive astrocytes.
• To elucidate the role of astrocyte transitions in neuroinflammation and neurodegenerative conditions.
• To identify therapeutic targets for modulating astrocyte function.

Main Methods:

• Time-series multiomic sequencing to track astrocyte states.
• Analysis of astrocyte populations in Alzheimer's disease (AD) and aging models.
• Genetic and pharmacological targeting of the mTOR signaling pathway in astrocytes.

Main Results:

• Astrocytes transition through neuroprotective and neurotoxic states, not distinct subtypes.
• The mechanistic target of rapamycin (mTOR) signaling pathway regulates this transition.
• An imbalance of these states was observed in AD and aging.
• Targeting astrocyte mTOR with rapamycin or shRNA reduced neurotoxicity in mouse models.

Conclusions:

• Astrocytes exhibit dynamic functional changes, transitioning from neuroprotection to neurotoxicity during neuroinflammation.
• mTOR signaling in astrocytes is a key regulator of this transition.
• Modulating astrocyte mTOR presents a potential therapeutic strategy for neurodegenerative diseases.